- Home
- LTM vs GKOS Comparison
LTM vs GKOS Comparison
Compare LTM & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTM
- GKOS
- Stock Information
- Founded
- LTM 1929
- GKOS 1998
- Country
- LTM Chile
- GKOS United States
- Employees
- LTM N/A
- GKOS N/A
- Industry
- LTM
- GKOS Medical/Dental Instruments
- Sector
- LTM
- GKOS Health Care
- Exchange
- LTM NYSE
- GKOS Nasdaq
- Market Cap
- LTM 8.8B
- GKOS 7.4B
- IPO Year
- LTM N/A
- GKOS 2015
- Fundamental
- Price
- LTM $27.80
- GKOS $150.97
- Analyst Decision
- LTM Strong Buy
- GKOS Strong Buy
- Analyst Count
- LTM 3
- GKOS 13
- Target Price
- LTM $38.00
- GKOS $145.54
- AVG Volume (30 Days)
- LTM 201.6K
- GKOS 623.8K
- Earning Date
- LTM 01-01-0001
- GKOS 11-04-2024
- Dividend Yield
- LTM 0.00%
- GKOS N/A
- EPS Growth
- LTM N/A
- GKOS N/A
- EPS
- LTM 0.00
- GKOS N/A
- Revenue
- LTM $12,707,202,000.00
- GKOS $360,347,000.00
- Revenue This Year
- LTM $13.58
- GKOS $22.68
- Revenue Next Year
- LTM $6.94
- GKOS $24.98
- P/E Ratio
- LTM $10.68
- GKOS N/A
- Revenue Growth
- LTM 14.06
- GKOS 18.70
- 52 Week Low
- LTM $21.83
- GKOS $74.75
- 52 Week High
- LTM $29.13
- GKOS $151.12
- Technical
- Relative Strength Index (RSI)
- LTM N/A
- GKOS 62.92
- Support Level
- LTM N/A
- GKOS $137.60
- Resistance Level
- LTM N/A
- GKOS $147.50
- Average True Range (ATR)
- LTM 0.00
- GKOS 5.43
- MACD
- LTM 0.00
- GKOS 0.74
- Stochastic Oscillator
- LTM 0.00
- GKOS 99.16
About LTM LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS
LATAM Airlines Group SA operates as a passenger airline group. Geographically, the company operates in Brazil, Chile, Colombia, Ecuador, and Peru, along with international operations within Latin America and to Europe, the US, and the Caribbean. The firm generates its revenue from transporting passengers and cargo.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.